<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="../../css/uswds.min.css">
    <link rel="stylesheet" href="../../css/style.css">
    <link rel="stylesheet" href="../css/uswds.min.css">
    <link rel="stylesheet" href="../css/style.css">
    <link rel="stylesheet" href="css/uswds.min.css">
    <link rel="stylesheet" href="css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="/">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="/">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="/html/titles/title21.html">
                                    Title 21
                                </a><span>&nbsp/&nbsp</span>
                                <a href="/html/parts/21CFR522.html">Part 522
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 522.1720  Phenylbutazone.
                            </h3>
                            <p class="depth0"><em>(a)</em> Specifications--(1) Each milliliter of solution contains 100 milligrams (mg) of phenylbutazone.</p><p class="depth0"><em>(2)</em> Each milliliter of solution contains 200 mg of phenylbutazone.</p><p class="depth0"><em>(b)</em> Sponsors. See sponsor numbers in Sec. 510.600(c) of this chapter for use as in paragraph (c) of this section:</p><p class="depth0"><em>(1)</em> No. 054771 for use of product described in paragraph (a)(1) as in paragraph (c) of this section.</p><p class="depth0"><em>(2)</em> Nos. 000061, 000859, 054771, and 061623 for use of product described in paragraph (a)(2) as in paragraph (c) of this section.</p><p class="depth0"><em>(3)</em> Nos. 054628 and 058005 for use of product described in paragraph (a)(2) as in paragraph (c)(2) of this section.</p><p class="depth0"><em>(c)</em> Conditions of use--(1) Dogs--(i) Amount. Administer by intravenous injection 10 mg per pound of body weight daily in three divided doses, not to exceed 800 mg daily regardless of weight. Limit intravenous administration to 2 successive days. Oral medication may follow.</p><p class="depth0"><em>(ii)</em> Indications for use. It is used for the relief of inflammatory conditions associated with the musculoskeletal system.</p><p class="depth0"><em>(iii)</em> Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.</p><p class="depth0"><em>(2)</em> Horses--(i) Amount. Administer by intravenous injection 1 to 2 grams (g) per 1,000 pounds of body weight daily in three divided doses, not to exceed 4 g daily. Limit intravenous administration to not more than 5 successive days.</p><p class="depth0"><em>(ii)</em> Indications for use. For the relief of inflammatory conditions associated with the musculoskeletal system.</p><p class="depth0"><em>(iii)</em> Limitations. Do not use in horses intended for human consumption. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
[79 FR 16193, Mar. 25, 2014]</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>. Code available <a href="#">on Github.</a></h5>
      </div>
    </div>
  </footer>
  </body>
</html>
